EE+ POEM Archive
Cabotegravir is an effective option for PrEP in patients at risk for HIV infection
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Cabotegravir Is an Effective Option for PrEP in Patients at Risk for HIV Infection." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315487/all/Cabotegravir_is_an_effective_option_for_PrEP_in_patients_at_risk_for_HIV_infection.
Cabotegravir is an effective option for PrEP in patients at risk for HIV infection. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315487/all/Cabotegravir_is_an_effective_option_for_PrEP_in_patients_at_risk_for_HIV_infection. Accessed April 20, 2024.
Cabotegravir is an effective option for PrEP in patients at risk for HIV infection. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315487/all/Cabotegravir_is_an_effective_option_for_PrEP_in_patients_at_risk_for_HIV_infection
Cabotegravir Is an Effective Option for PrEP in Patients at Risk for HIV Infection [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315487/all/Cabotegravir_is_an_effective_option_for_PrEP_in_patients_at_risk_for_HIV_infection.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cabotegravir is an effective option for PrEP in patients at risk for HIV infection
ID - 1315487
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315487/all/Cabotegravir_is_an_effective_option_for_PrEP_in_patients_at_risk_for_HIV_infection
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
